The FDA approves a US company to conduct clinical trials of human transplant gene-edited pig kidneys.

The American biotechnology company "E Genesis" that researches gene-edited pig organs, said on the 8th that the US Food and Drug Administration has approved the company to conduct clinical trials of gene-edited pig kidneys for human transplants.